Related Experiment Video

Updated: Aug 6, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.6K

Arsenic resistance protein 2 and microRNA biogenesis: Biological implications in cancer development

Liang Yuan1, Xiuxing Jiang2, Qihai Gong1

  • 1Key Laboratory of Basic Pharmacology of Ministry of Education, Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou 563006, China.

Pharmacology & Therapeutics
|March 18, 2023
PubMed

Insights

Arsenic resistance protein 2 (Ars2) regulates microRNA (miRNA) biogenesis, impacting cell proliferation and development. Targeting Ars2 in cancer cells offers a promising new therapeutic strategy for cancer treatment.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • Arsenic resistance protein 2 (Ars2) is a nuclear protein crucial for microRNA (miRNA) biogenesis.
  • Ars2 function is essential for cell proliferation and mammalian development, potentially via miRNA processing.
  • Elevated Ars2 expression is observed in proliferating cancer cells, indicating its oncogenic role.

Purpose of the Study:

  • To review the mechanisms of Ars2 in miRNA biogenesis and its impact on cell proliferation.
  • To discuss the role of Ars2 in cancer development.
  • To highlight the potential of targeting Ars2 as a cancer therapeutic strategy.

Main Methods:

  • Literature review of Ars2 function in miRNA biogenesis.
  • Analysis of Ars2's role in cell proliferation and cancer development.
  • Examination of pharmacological targeting of Ars2.

Main Results:

  • Ars2 is a key regulator of miRNA biogenesis.
  • Ars2 influences cell proliferation and is implicated in cancer development.
  • Inhibitors of Ars2 show promise as a therapeutic strategy.

Conclusions:

  • Ars2 plays a significant role in miRNA biogenesis and cancer progression.
  • Targeting Ars2 presents a novel and promising therapeutic avenue for cancer treatment.
Keywords:
Arsenic resistance protein 2Cell proliferationRNA-induced silencing complexThe nuclear cap-binding complexcancermiRNA biogenesis

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.4K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K